Trial registration in pediatric surgery trials

Sana Rokhsefat1, Deanna E Morra1, Martin Offringa2

  • 1Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Canada.

Insights

Pediatric surgical trial registration is poor, with low registration rates and incomplete data. This highlights the need for improved prospective registration to ensure transparent and reproducible research in pediatric surgery.

Area of Science:

  • Clinical Trials
  • Pediatric Surgery
  • Research Transparency

Background:

  • Prospective clinical trial registration enhances transparency and reduces selective reporting bias.
  • Previous studies indicated poor registration practices in adult surgical trials.
  • The status of pediatric surgical trial registration was previously unknown.

Purpose of the Study:

  • To determine the proportion of pediatric surgical trials published in 2014 that were prospectively registered.
  • To assess the adequacy and completeness of the registration data for these trials.

Main Methods:

  • A systematic search of MEDLINE identified prospective pediatric intervention studies published in 2014.
  • Pediatric surgical trials were selected, and their registration numbers were verified in trial registries.
  • Data completeness was assessed using the WHO minimum data set, comparing registry information with publication data.

Main Results:

  • Only 28% of the 54 analyzed pediatric surgical trials published a registration number.
  • Among registered trials, 40% were registered retrospectively, and 40% altered their primary/secondary outcomes.
  • One trial reported an incorrect registration number.

Conclusions:

  • Pediatric surgery trials published in 2014 demonstrated a low rate of prospective registration and incomplete registration data.
  • Initiatives to improve prospective trial registration are crucial for generating high-quality, transparent, and reproducible evidence in pediatric surgery.
Abstract

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
258
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
338